Novel pegylated interferon‐β as strong suppressor of the malignant ascites in a peritoneal metastasis model of human cancer

Malignant ascites manifests as an end‐stage event during the progression of a number of cancers and lacks a generally accepted standard therapy. Interferon‐β (IFN‐β) has been used to treat several cancer indications; however, little is known about the efficacy of IFN‐β on malignant ascites. In the p...

Descripción completa

Detalles Bibliográficos
Autores principales: Iwamura, Tomokatsu, Narumi, Hideki, Suzuki, Tomohiko, Yanai, Hideyuki, Mori, Katsuyuki, Yamashita, Koji, Tsushima, Yoshiaki, Asano, Tomomi, Izawa, Akiko, Momen, Shinobu, Nishimura, Kazumi, Tsuchiyama, Hiromi, Uchida, Masashi, Yamashita, Yuji, Okano, Kiyoshi, Taniguchi, Tadatsugu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2017
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5406538/
https://www.ncbi.nlm.nih.gov/pubmed/28129467
http://dx.doi.org/10.1111/cas.13176

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5406538/
https://www.ncbi.nlm.nih.gov/pubmed/28129467
http://dx.doi.org/10.1111/cas.13176

Ejemplares similares